TOT BIOPHARM Reached New Milestones in Interim -2- : compare

DJ TOT BIOPHARM Reached New Milestones in Interim Results, with Sales Volume of over RMB 100 million, a Significantly Improved Capital Structure EQS Newswire / 15/08/2022 / 10:26 UTC+8 TOT BIOPHARM

Related Keywords

China , Hong Kong , Jixin , Hainan , Tibet Autonomous Region , Xizang , Hebei , Jilin , Suzhou , Jiangsu , Macao , Macau General , Macau , Kostenloser Wertpapierhandel , Global Research , Kexing Biopharm Co Ltd , Governance Committee , Zhaoke Guangzhou Ophthalmology Pharmaceutical , Zhaoke Ophthalmology , Construction Of The Company Global Research , Development Center , International Company Limited , Vivo Capital , Frontier Biotechnologies Inc , Financial Press , Center Laboratories Inc , New Milestones , Interim Results , Sales Volume , Significantly Improved Capital Structure , Year On Increase , Operating Revenue , Year On Decrease , Net Loss , Company Limited , Jixin Pharmaceutical , Thirteen Allied Provinces , Jiangsu Province , Frontier Biotechnologies , Key Product Pipelines , Zhaoke Guangzhou , Ophthalmology Pharmaceutical Limited , Zhaoke Ophthalmology Limited , Health Industry Investment Fund , Center Laboratories , Chief Executive Officer , Chief Science Officer , Executive Director , Dow Jones Newswires , Financial Press Release , Debiopharm , Eached , Ilestones , Interim ,